These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27209345)

  • 21. Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.
    Bello L; Campadello P; Barp A; Fanin M; Semplicini C; Sorarù G; Caumo L; Calore C; Angelini C; Pegoraro E
    Sci Rep; 2016 Sep; 6():32439. PubMed ID: 27582364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Magnetic resonance imaging of dystrophinopathy that mimics adductor enthesopathy].
    Zheng YM; Li WZ; Wang ZX; Zhang W; Lv H; Xiao JX; Yuan Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):846-849. PubMed ID: 27752168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients.
    Wokke BH; Van Den Bergen JC; Hooijmans MT; Verschuuren JJ; Niks EH; Kan HE
    Muscle Nerve; 2016 Jan; 53(1):38-43. PubMed ID: 25847364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
    Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
    J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy.
    Nagy S; Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Bieri O; Vuillerot C; Bonati U; Fischer D
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30688316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.
    Arora H; Willcocks RJ; Lott DJ; Harrington AT; Senesac CR; Zilke KL; Daniels MJ; Xu D; Tennekoon GI; Finanger EL; Russman BS; Finkel RS; Triplett WT; Byrne BJ; Walter GA; Sweeney HL; Vandenborne K
    Muscle Nerve; 2018 Nov; 58(5):631-638. PubMed ID: 29742798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeatability of Dixon magnetic resonance imaging and magnetic resonance spectroscopy for quantitative muscle fat assessments in the thigh.
    Grimm A; Meyer H; Nickel MD; Nittka M; Raithel E; Chaudry O; Friedberger A; Uder M; Kemmler W; Engelke K; Quick HH
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1093-1100. PubMed ID: 30221479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative muscle magnetic resonance imaging in limb-girdle muscular dystrophy type R1 (LGMDR1): A prospective longitudinal cohort study.
    Forsting J; Wächter M; Froeling M; Rohm M; Güttsches AK; De Lorenzo A; Südkamp N; Kocabas A; Vorgerd M; Enax-Krumova E; Rehmann R; Schlaffke L
    NMR Biomed; 2024 Oct; 37(10):e5172. PubMed ID: 38794994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.
    Kim HK; Laor T; Horn PS; Racadio JM; Wong B; Dardzinski BJ
    Radiology; 2010 Jun; 255(3):899-908. PubMed ID: 20501727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal changes in magnetic resonance imaging biomarkers of the gluteal muscle groups and functional ability in Duchenne muscular dystrophy: a 12-month cohort study.
    Song Y; Xu K; Xu HY; Guo YK; Xu R; Fu H; Yuan WF; Zhou ZQ; Xu T; Chen XJ; Wang YL; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Dec; 53(13):2672-2682. PubMed ID: 37889296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle water T
    Mankodi A; Azzabou N; Bulea T; Reyngoudt H; Shimellis H; Ren Y; Kim E; Fischbeck KH; Carlier PG
    Neuromuscul Disord; 2017 Aug; 27(8):705-714. PubMed ID: 28601553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric quantitative MRI assessment of thigh muscles in limb-girdle muscular dystrophy 2A and 2B.
    Arrigoni F; De Luca A; Velardo D; Magri F; Gandossini S; Russo A; Froeling M; Bertoldo A; Leemans A; Bresolin N; D'angelo G
    Muscle Nerve; 2018 Oct; 58(4):550-558. PubMed ID: 30028523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between lower extremity muscle fat fraction and motor performance in myotonic dystrophy type 2: A pilot study.
    Madrid DA; Knapp RA; Lynch D; Clemens P; Weaver AA; Puwanant A
    Muscle Nerve; 2023 Jun; 67(6):506-514. PubMed ID: 36938823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.
    Polavarapu K; Manjunath M; Preethish-Kumar V; Sekar D; Vengalil S; Thomas P; Sathyaprabha TN; Bharath RD; Nalini A
    Neuromuscul Disord; 2016 Nov; 26(11):768-774. PubMed ID: 27666775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of T1-Mapping for the pelvic and thigh muscles in Duchenne Muscular Dystrophy: a quantitative biomarker for disease involvement and correlation with clinical assessments.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    BMC Musculoskelet Disord; 2022 Jul; 23(1):681. PubMed ID: 35842609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Poulsen NS; Østergaard ST; Fornander F; de Stricker Borch J; Danielsen ER; Thomsen C; Vissing J
    Neurology; 2020 Sep; 95(9):e1211-e1221. PubMed ID: 32611642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Extracellular Volume Fraction in Becker Muscular Dystrophy by Using MR Fingerprinting.
    Marty B; Baudin PY; Caldas de Almeida Araujo E; Fromes Y; Wahbi K; Reyngoudt H
    Radiology; 2023 May; 307(3):e221115. PubMed ID: 36880945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orofacial muscles may be affected in early stages of Becker muscular dystrophy: A preliminary study.
    Lagarde MLJ; van Alfen N; Geurts ACH; de Groot IJM; van den Engel-Hoek L
    Muscle Nerve; 2020 Feb; 61(2):213-217. PubMed ID: 31778229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.